We caught up with Dr Bimal Shah at the ADA annual meeting in San Francisco to discuss Livongo’s latest study, which demonstrated that 94% of Livongo for Diabetes program Members who completed a program survey achieved improved Diabetes Empowerment Scale or Diabetes Distress Scale in year one of the Livongo for Diabetes Program.
Questions
1. What were the study findings? (0:05)
2. Can you explain the Diabetes Empowerment Scale-Short Form (DES-SF) and the Diabetes Distress Scale 2 (DDS2) and why they are significant? (0:47)
3. Can you tell me a bit more about the study details and participants? (2:10)
4. What else did you find impactful about the study? (2:49)
5. Why is it important for digital health companies to conduct research like this? (3:45)
Bimal Shah has no conflicts of interest in relation to this video.
touchENDO.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.
